JPM vs RLYB · P/E 14, rev $57.35B vs rev $212.0K
JPMorgan Chase & Co (JPM) versus Rallybio Corp (RLYB) — a side-by-side from cached financials, not a winner call.
JPMorgan Chase & Co (JPM) is a banks - diversified company listed on US. It is led by James Dimon.
Rallybio Corp (RLYB) is a biotechnology company listed on US.
Latest reported JPM revenue for 2026-06-30 was $57.35B. Net income was $21.16B. Revenue was up 15.1% from 2026-03-31 to 2026-06-30. JPM currently screens at market cap $805.69B and trailing P/E 14.2.
Latest reported RLYB revenue for 2026-06-30 was $212.0K. Net income was $35.4M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. RLYB currently screens at market cap $13.8M.
JPM currently screens at market cap $805.69B and trailing P/E 14.2. RLYB currently screens at market cap $13.8M.
Not investment advice. Open the JPM and RLYB stock pages for the full models.
Not investment advice.